Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. B. Duggan
Fifteen-Year Median Follow-Up Results After Neoadjuvant Doxorubicin, Followed by Mastectomy, Followed by Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) Followed by Radiation for Stage III Breast Cancer: A Phase II Trial (CALGB 8944)
Breast Cancer Research and Treatment
Cancer Research
Oncology
Related publications
P2-033Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel Dose Dense in Stage III Breast Cancer
Annals of Oncology
Medicine
Oncology
Hematology
CRITICS-II: A Multicentre Randomised Phase II Trial of Neo-Adjuvant Chemotherapy Followed by Surgery Versus Neo-Adjuvant Chemotherapy and Subsequent Chemoradiotherapy Followed by Surgery Versus Neo-Adjuvant Chemoradiotherapy Followed by Surgery in Resectable Gastric Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Neoadjuvant 5-Fluorouracil, Epirubicin and Cyclophosphamide Chemotherapy Followed by Docetaxel in Refractory Patients With Locally Advanced Breast Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer (Registration Number: ChiCTR1900023052)
Scientific Reports
Multidisciplinary
Neoadjuvant Chemotherapy Followed by Radiotherapy for Laryngeal Cancer
Journal of Biomedicine
Epirubicin/Cyclophosphamide Followed by Docetaxel as Primary Systemic Therapy in Breast Cancer
Annals of Cancer Research and Therapy
Cancer Research
Oncology
Pharmacology
Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation in the Treatment of Pleural Mesothelioma
BMC Cancer
Cancer Research
Oncology
Genetics
Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-Per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
A Feasibility Study of Bevacizumab Plus Dose-Dense Doxorubicin-Cyclophosphamide (AC) Followed by Nanoparticle Albumin-Bound Paclitaxel in Early-Stage Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
